A. Mark Fendrick
#142,438
Most Influential Person Now
A. Mark Fendrick's AcademicInfluence.com Rankings
A. Mark Fendrickphilosophy Degrees
Philosophy
#7486
World Rank
#10707
Historical Rank
Logic
#4530
World Rank
#5839
Historical Rank

Download Badge
Philosophy
Why Is A. Mark Fendrick Influential?
(Suggest an Edit or Addition)A. Mark Fendrick's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An evidence-based appraisal of reflux disease management — the Genval Workshop Report (1998) (935)
- Willingness to Pay for a Quality-adjusted Life Year (2000) (902)
- The economic burden of non-influenza-related viral respiratory tract infection in the United States. (2003) (738)
- What is the price of life and why doesn't it increase at the rate of inflation? (2003) (582)
- National estimates of the quantity and cost of informal caregiving for the elderly with dementia (2001) (430)
- Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease (2001) (385)
- The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. (2003) (372)
- Suboptimal statin adherence and discontinuation in primary and secondary prevention populations (2004) (352)
- Impact of decreasing copayments on medication adherence within a disease management environment. (2008) (332)
- The Health Effects of Restricting Prescription Medication Use Because of Cost (2004) (325)
- Public use of automated external defibrillators. (2003) (317)
- Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis (2003) (265)
- Value-based insurance design. (2007) (237)
- Estimating the cost of informal caregiving for elderly patients with cancer. (2001) (217)
- A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001) (207)
- Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease (1995) (204)
- Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers (2013) (186)
- Dizziness presentations in U.S. emergency departments, 1995-2004. (2008) (179)
- A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis (1993) (165)
- Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States (2004) (162)
- Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. (2004) (156)
- Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications (2008) (151)
- Helicobacter pylori-related disease: guidelines for testing and treatment. (2000) (149)
- The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. (2000) (146)
- Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes (2005) (144)
- Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis (2001) (143)
- Extent and cost of informal caregiving for older Americans with symptoms of depression. (2004) (143)
- Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008) (140)
- Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs (2003) (138)
- Predicting Nursing Home Admission: Estimates From a 7-Year Follow-up of a Nationally Representative Sample of Older Americans (2004) (137)
- Out-of-pocket health-care expenditures among older Americans with cancer. (2004) (135)
- Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. (2003) (131)
- Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. (2001) (128)
- A national study of the quantity and cost of informal caregiving for the elderly with stroke (2002) (118)
- Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? (2004) (118)
- The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. (1996) (112)
- Comparing local and regional variation in health care spending. (2012) (111)
- Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. (1996) (101)
- Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. (1999) (101)
- Nystagmus assessments documented by emergency physicians in acute dizziness presentations: a target for decision support? (2011) (101)
- Managed Care, Medical Technology, and Health Care Cost Growth: A Review of the Evidence (1998) (100)
- Evidence that value-based insurance can be effective. (2010) (97)
- Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. (1992) (95)
- As tests evolve and costs of cancer care rise: reappraising stool‐based screening for colorectal neoplasia (2008) (89)
- Informal caregiving for diabetes and diabetic complications among elderly americans. (2002) (85)
- Stroke risk stratification in acute dizziness presentations (2015) (83)
- Low-Cost, High-Volume Health Services Contribute The Most To Unnecessary Health Spending. (2017) (79)
- Summing the risk of NSAID therapy (2007) (78)
- Associations in breast and colon cancer screening behavior in women. (2005) (77)
- Behavioral associations between prostate and colon cancer screening. (2005) (72)
- Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. (2006) (72)
- Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. (2002) (69)
- Is sepsis accurately coded on hospital bills? (2002) (69)
- Use of BPPV Processes in Emergency Department Dizziness Presentations (2013) (68)
- "We got mail": electronic communication between physicians and patients. (1999) (67)
- Cost-effectiveness of automated external defibrillator deployment in selected public locations (2003) (66)
- Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. (1996) (65)
- Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. (2003) (65)
- The costs of cancer to a major employer in the United States: a case-control analysis. (2000) (64)
- Diagnosis and treatment of upper respiratory tract infections in the primary care setting. (2001) (60)
- Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis (2002) (60)
- A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis (2009) (60)
- Informal caregiving for chronic lung disease among older Americans. (2002) (59)
- Respiratory illness caused by picornavirus infection: a review of clinical outcomes (2001) (59)
- Economic Evaluation of Vaccination Programmes (2002) (58)
- The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance (2013) (58)
- Quality Of Life Measurement Clarifies The Cost-Effectiveness Of Helicobacter Pylori Eradication In Peptic Ulcer Disease And Uninvestigated Dyspepsia (2001) (57)
- Acute exacerbation of chronic bronchitis: a primary care consensus guideline. (2004) (57)
- Primary-Care Physicians' Perceptions and Practices on the Management of GERD: Results of a National Survey (2005) (55)
- Cost-utility of aspirin and proton pump inhibitors for primary prevention. (2011) (53)
- Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. (2006) (52)
- Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs (2005) (51)
- Applying value-based insurance design to low-value health services. (2010) (50)
- Measuring Health-Related Quality of Life in Patients with Upper Gastrointestinal Disease (1998) (50)
- Value of computed tomography scans in ED dizziness visits: analysis from a nationally representative sample. (2010) (49)
- Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. (1998) (49)
- The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. (1999) (47)
- The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment (1996) (46)
- Managed care and medical technology: implications for cost growth. (1997) (46)
- Stroke risk after nonstroke emergency department dizziness presentations (2014) (45)
- Approval times for new drugs: does the source of funding for FDA staff matter? (2003) (45)
- OTC analgesics and drug interactions: clinical implications (2008) (44)
- Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. (1996) (43)
- Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis. (1999) (43)
- Viral Respiratory Infections Due to Rhinoviruses: Current Knowledge, New Developments (2003) (42)
- Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience. (2003) (42)
- Value-Based Insurance Design Improves Medication Adherence Without An Increase In Total Health Care Spending. (2018) (40)
- Value-Based Insurance Design: A “Clinically Sensitive, Fiscally Responsible” Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans (2007) (39)
- Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis. (2003) (38)
- The Effect of a Large Regional Health Plan’s Value-based Insurance Design Program on Statin Use (2012) (38)
- Out-of-Pocket Health Care Expenditures Among Older Americans with Dementia (2004) (38)
- Health plan report cards: exploring differences in plan ratings. (1998) (37)
- Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. (2001) (37)
- A prescription for the Epley maneuver: www.youtube.com? (2012) (36)
- Barriers to constraining health care cost growth. (2004) (35)
- Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. (2003) (35)
- Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis. (2002) (35)
- Hospital adoption of laparoscopic cholecystectomy. (1994) (34)
- Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. (2004) (34)
- Cost-Effectiveness of the Screening and Treatment of Diabetic Retinopathy: What Are the Costs of Underutilization? (1992) (34)
- The evidence base for the evaluation and management of dizziness. (2010) (33)
- Asymptomatic gallstones revisited. Is there a role for laparoscopic cholecystectomy? (1993) (33)
- Variation in medication adherence in heart failure. (2013) (33)
- PPI use in the OTC era: who to treat, with what, and for how long? (2005) (33)
- Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018 (2021) (33)
- Waiting for Care: Queuing and Resource Allocation (1987) (32)
- New and Dis-Improved: On the Evaluation and Use of Less Effective, Less Expensive Medical Interventions (2004) (32)
- Cardiologists performing peripheral angioplasties: impact on utilization. (2001) (31)
- Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States (2002) (31)
- Medication Adherence and Heart Failure (2014) (31)
- Economic analysis in dermatology. (2002) (30)
- Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy (2001) (30)
- Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. (1999) (30)
- Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. (2000) (29)
- Improving cancer screening adherence: using the "teachable moment" as a delivery setting for educational interventions. (2004) (29)
- Potential clinical and economic effects of homocyst(e)ine lowering. (2000) (29)
- Value-based insurance design: embracing value over cost alone. (2009) (29)
- Effects of Episode-Based Payment on Health Care Spending and Utilization: Evidence from Perinatal Care in Arkansas (2017) (29)
- Cost‐effectiveness analysis: cardiovascular benefits of proton pump inhibitor co‐therapy in patients using aspirin for secondary prevention (2011) (29)
- Cost-effectiveness of saline-assisted hysterosonography and office hysteroscopy in the evaluation of postmenopausal bleeding: a decision analysis. (2001) (28)
- Value-based insurance design: aligning incentives, benefits, and evidence in oncology. (2012) (28)
- Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. (2001) (28)
- Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? (2004) (28)
- Global Budgets and Technology-Intensive Medical Services. (2013) (27)
- Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death (2005) (27)
- The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas (2000) (27)
- Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. (1997) (27)
- Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence. (2016) (27)
- The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial. (2005) (27)
- Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention. (2008) (26)
- Fast food franchises in hospitals. (2002) (26)
- Right-Sizing Prenatal Care to Meet Patients' Needs and Improve Maternity Care Value. (2020) (26)
- Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis (2001) (26)
- Cost-effectiveness comparison of therapy for psoriasis with a methotrexate-based regimen versus a rotation regimen of modified cyclosporine and methotrexate. (2002) (26)
- The role of economic evaluation in infection control. (2001) (25)
- Provider knowledge, attitudes, and treatment preferences for early pregnancy failure. (2010) (25)
- Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. (2019) (25)
- Value-based insurance design: more health at any price. (2012) (25)
- Improved health benefits of increased use of thrombolytic therapy. (1994) (24)
- Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension. (2003) (24)
- Diagnostic testing for influenza: review of current status and implications of newer treatment options. (1999) (24)
- Women's health and the Affordable Care Act: high hopes versus harsh realities? (2014) (24)
- Defining cause of death in stroke patients: The Brain Attack Surveillance in Corpus Christi Project. (2006) (23)
- Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy (2002) (23)
- Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? (2005) (23)
- Changes in peptic ulcer and gastritis/duodenitis in Great Britain, 1970-1985. (1990) (23)
- The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. (2012) (23)
- A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial (2009) (22)
- Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists (2001) (22)
- Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. (2003) (22)
- Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection? (1999) (22)
- A Clinician's Guide to the Selection of NSAID Therapy (2002) (21)
- Price elasticity and medication use: cost sharing across multiple clinical conditions. (2014) (21)
- Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers (2008) (21)
- Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists (2006) (21)
- Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015. (2020) (20)
- Decomposing pharmaceutical cost growth in different types of health plans. (2001) (20)
- Value based insurance design: maintaining a focus on health in an era of cost containment. (2009) (20)
- Rising out-of-pocket costs in disease management programs. (2006) (20)
- The spectrum of acute bronchitis (2001) (20)
- Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis. (1999) (19)
- Pharmaceutical cost growth under capitation: a case study. (2000) (19)
- PATIENT, PHYSICIAN, AND PAYER PERCEPTIONS AND MISPERCEPTIONS OF WILLINGNESS TO PAY FOR DIAGNOSTIC CERTAINTY (2000) (18)
- NSAIDs without a prescription: over-the-counter access, under-counted risks (2002) (18)
- Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008-15. (2020) (18)
- The dynamics of innovation in minimally invasive therapy. (1993) (18)
- Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia. (2004) (18)
- Treatment of early pregnancy failure: does induced abortion training affect later practices? (2011) (18)
- Automated External Defibrillator Deployment in High Schools andSenior Centers (2005) (17)
- Value-based insurance design: benefits beyond cost and utilization. (2015) (17)
- Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy. (2002) (17)
- The impact of cost sharing on women's use of annual examinations and effective contraception (2018) (17)
- The Tension Between Cost Containment and the Underutilization of Effective Health Services (1996) (17)
- Coronary artery bypass grafting in octogenarians: clinical and economic outcomes at community-based healthcare facilities. (2002) (17)
- Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act. (2019) (17)
- Primary care physician perceptions of non‐steroidal anti‐inflammatory drug and aspirin‐associated toxicity: results of a national survey (2006) (17)
- Management of patients with symptomatic gastroesophageal reflux disease: a primary care perspective. (2001) (17)
- Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia. (2006) (16)
- A Survey Of Americans With High-Deductible Health Plans Identifies Opportunities To Enhance Consumer Behaviors. (2019) (15)
- Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel Meeting. (2016) (15)
- A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy--a comparison of sequential sigmoidoscopy and colonoscopy with immediate conversion from sigmoidoscopy to colonoscopy in patients with an abnormal screening sigmoidoscopy. (2000) (15)
- Value and increased cost sharing in the American health care system. (2008) (15)
- Cost of contraceptive methods to privately insured women in the United States. (2013) (15)
- Primary care physicians perceptions and practices on the management of GERD: Results of a national survey (2003) (15)
- Cost-effectiveness of colorectal cancer screening strategies. (1996) (15)
- Adherence to Competing Colorectal Cancer Screening Strategies: 1065 (2005) (14)
- Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model (2020) (14)
- Precision Benefit Design-Using "Smarter" Deductibles to Better Engage Consumers and Mitigate Cost-Related Nonadherence. (2017) (14)
- Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes Treatment (2019) (14)
- Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits. (2003) (14)
- The impact of including passive benefits in cost-effectiveness analysis: the case of automated external defibrillators on commercial aircraft. (2003) (13)
- Beyond usual care: the economic consequences of expanding treatment options in early pregnancy loss. (2015) (13)
- Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia. (2002) (13)
- Consumer Behaviors Among Individuals Enrolled in High-Deductible Health Plans in the United States (2017) (13)
- Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. (2002) (13)
- Accelerating Approval Times for New Drugs in the U.S (2004) (13)
- COX-2 inhibitor use after Vioxx: careful balance or end of the rope? (2004) (13)
- The role of economic evaluation in the diagnosis and treatment of Helicobacter pylori infection. (2000) (13)
- Improving Benefit Design to Promote Effective, Efficient, and Affordable Care. (2016) (13)
- Geographic Variation in Quality of Care for Commercially Insured Patients (2014) (13)
- Innovation of novel antibiotics: an economic perspective. (2014) (12)
- Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis. (1996) (12)
- The effect of medical malpractice liability on rate of referrals received by specialist physicians (2013) (12)
- Real-world impact of comparative effectiveness research findings on clinical practice. (2014) (12)
- Differences in the reporting of care-related patient injuries to existing reporting systems. (2003) (12)
- How to test for Helicobacter pylori in 2005. (2005) (12)
- A pharmacoeconomic perspective on stroke prevention in atrial fibrillation. (2010) (11)
- Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency? (2020) (11)
- IN2: THE ECONOMIC BURDEN OF VIRAL RESPIRATORY INFECTION IN THE UNITED STATES (2001) (11)
- Emergency department documentation templates: variability in template selection and association with physical examination and test ordering in dizziness presentations (2011) (11)
- Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. (2005) (11)
- Trends in Patient Cost Sharing for Clinical Services Used as Quality Indicators (2010) (11)
- Value-based insurance design in oncology. (2011) (11)
- Availability and variation of publicly reported prescription drug prices. (2017) (10)
- Treatment patterns for early pregnancy failure in Michigan. (2009) (10)
- The Impact of Global Budgets on Pharmaceutical Spending and Utilization (2014) (10)
- “The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Case of Katie Couric” (2003) (10)
- "Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality. (2007) (10)
- Coronary artery bypass grafting in Native Americans: a higher risk of death compared to other ethnic groups? (2001) (10)
- Impact of Initial Triage Decisions on Nursing Intensity for Patients With Acute Chest Pain (1990) (10)
- Outcomes research in Helicobacter pylori infection (1997) (10)
- Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori“ Test and Treat” strategy for patients with suspected peptic ulcer disease? (2000) (10)
- Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk (2021) (9)
- Description and Validation of the Colorectal Cancer and Adenoma Incidence & Mortality (CRC-AIM) Microsimulation Model (2020) (9)
- Practical advice on eradicating Helicobacter pylori infection. (1999) (9)
- Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. (1996) (8)
- Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women. (2019) (8)
- Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population (2019) (8)
- Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care (2015) (8)
- Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia (2001) (8)
- Out-of-Pocket Costs of Diagnostic Breast Imaging Services After Screening Mammography Among Commercially Insured Women From 2010 to 2017 (2021) (8)
- Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care. (2002) (8)
- Value-based insurance design: implications for gastroenterology. (2010) (8)
- Gastroenterologists utilize the referral for EGD to enhance colon cancer screening more effectively than primary care physicians (2006) (8)
- IDENTIFICATION OF PATIENTS WITH RESECTABLE PANCREATIC CANCER: AT WHAT STAGE ARE WE? (1998) (8)
- Trends in Birth Rates After Elimination of Cost Sharing for Contraception by the Patient Protection and Affordable Care Act (2020) (8)
- Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance. (2021) (8)
- Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori “Test and Treat” strategy for patients with suspected peptic ulcer disease? (2000) (8)
- The future of health economic modeling: have we gone too far or not far enough? (2006) (7)
- Coronary artery bypass grafting in Native Americans (2001) (7)
- Medicare Advantage: Issues, Insights, and Implications for the Future (2016) (7)
- Willingness to pay for diagnostic certainty (1999) (7)
- The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA (2022) (7)
- Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment. (1998) (7)
- Willingness to pay for diagnostic certainty: comparing patients, physicians, and managed care executives. (1999) (7)
- Using clinically nuanced cost sharing to enhance consumer access to specialty medications. (2014) (7)
- Value-based insurance design in cardiology: using "clinical nuance" to improve quality of care and contain costs. (2012) (7)
- Gaps in Treatment, Treatment Resumption, and Cost Sharing (2012) (7)
- Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019 (2021) (7)
- Helicobacter pylori and NSAID gastropathy: An ambiguous association (2001) (7)
- The effectiveness initiative. II: The spectrum of effectiveness research. (1995) (7)
- Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality. (2006) (7)
- Effect of a Nurse-Led Psychoeducational Intervention on Healthcare Service Utilization Among Adults With Advanced Cancer. (2015) (7)
- Percutaneous Stenting of Incidental Unilateral Renal Artery Stenosis: Decision Analysis of Costs and Benefits (2003) (6)
- Electron beam computed tomography in the diagnosis of obstructive coronary artery disease. (2001) (6)
- Developments in Influenza Prevention and Treatment (2000) (6)
- Helicobacter pylori-more light, less heat (1998) (6)
- The Price Will Be Right-How to Help Patients and Providers Benefit from the New CMS Transparency Rule. (2021) (6)
- Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population (2021) (6)
- The Costs of Cancer: Cancer-related Conditions Can Add Dramatically to Overall Costs of Care (2002) (6)
- Attitudes About Consumer Strategies Among Americans in High-deductible Health Plans (2019) (6)
- Treatment of Symptomatic Cholelithiasis in France: A Decision Analysis Comparing Cholecystectomy and Biliary Lithotripsy (1992) (6)
- How Would Low-Income Communities Prioritize Medicaid Spending? (2020) (6)
- Breast Screening Utilization and Cost Sharing Among Employed Insured Women Following the Affordable Care Act: Impact of Race and Income. (2019) (6)
- Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency. (2019) (6)
- Incorporating Value-Based Care Into Oncology. (2020) (6)
- Assessment of Self-monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin (2019) (6)
- Surprise Billing for Colonoscopy: The Scope of the Problem (2020) (6)
- GASTROESOPHAGEAL REFLUX : THERAPY CONSIDERATIONS AFTER FAILURE OF LOW-DOSE, NONPRESCRIPTION H2RAS (1999) (5)
- Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured (2021) (5)
- Therapeutic options for GERD: what's the correct approach? (2000) (5)
- GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIA. (2018) (5)
- Utilization Impact of Cost-Sharing Elimination for Preventive Care Services: A Rapid Review (2021) (5)
- Utilization and outcomes of office-based testing for Helicobacter pylori (HP) in symptomatic primary care patients (1998) (5)
- A path to improve colorectal cancer screening outcomes: faculty roundtable evaluation of cost-effectiveness and utility. (2020) (5)
- Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model (2020) (5)
- Waste in the Medicare Program: a National Cross-Sectional Analysis of 2017 Low-Value Service Use and Spending (2020) (5)
- Surgeon predictions on growth of minimal invasive therapy: the difficulty of estimating technologic diffusion. (2000) (5)
- The effectiveness initiative. I. Medical practice guidelines. (1995) (5)
- A commentary on the potential of Value-Based Insurance Design (VBID) to contain costs and preserve quality (2008) (5)
- COMPARATIVE RESEARCH Direct Medical Care Costs of Unstable Angina Pectoris in a Defined Population (2015) (5)
- Value added radiology: using existing radiology services to improve cancer screening. (2005) (5)
- Cost-effectiveness of symptomatic gallstone management: what exactly are we measuring? (1992) (4)
- Cost Analysis of Transthoracic Cardioversion of Atrial Fibrillation With and Without Ibutilide Pretreatment (2000) (4)
- Impact of NSAID choice and patient symptoms on the cost-effectiveness of strategies to prevent NSAID gastropathy (1998) (4)
- Value-based insurance coverage for bariatric surgery: time for surgeons to lead the change. (2019) (4)
- 188: Dizziness Presentations in U.S. Emergency Departments, 1995-2004: Doing More, Getting Less? (2008) (4)
- Value-based insurance design: aligning incentives and evidence in pulmonary medicine. (2013) (4)
- Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients. (2020) (4)
- Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care. (2021) (4)
- The Utilization and Costs of Grade D USPSTF Services in Medicare, 2007–2016 (2021) (4)
- Regional Variation in Medication Adherence (2011) (4)
- Inside out: reversing the focus on emergency departments to enhance efficiency. (2013) (4)
- Cost-Sharing, Postpartum Contraceptive Use, and Short Interpregnancy Interval Rates Among Commercially Insured Women. (2020) (4)
- Management of patients with known duodenal ulcer disease but unknown Helicobacter pylori status (1995) (4)
- Understanding the Behavioral Response to Medical Innovation (1996) (4)
- Allergen-Induced Inflammation and the Role of Immunoglobulin E (IgE) (2001) (3)
- Novel multicancer early detection technology-potential value to employers and the workforce. (2020) (3)
- Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population (2021) (3)
- Naloxone fi ll rates after opioid overdose (2019) (3)
- Mo1598 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL (2020) (3)
- Value Based Insurance Design: Restoring Health To The Health Care Cost Debate (2009) (3)
- Homocyst(e)ine and Coronary Heart Disease (2012) (3)
- Financial Burden of Advanced Imaging in Radiology (FAIR Study) (2022) (3)
- Levers to reduce use of unnecessary services: creating needed headroom to enhance spending on evidence-based care. (2018) (3)
- Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit. (2021) (3)
- The Arkansas Payment Improvement Initiative: Early Perceptions of Multi-Payer Reform in a Fragmented Provider Landscape (2015) (3)
- Out-Of-Pocket Payments for Part D Covered Medications by Medicare Fee-For-Service Beneficiaries with Heart Failure with Reduced Ejection Fraction. (2021) (3)
- A Care Coordination Intervention Improves Symptoms but not Charges in High-Risk Patients with Inflammatory Bowel Disease. (2021) (3)
- Patient reported outcomes in genital gender-affirming surgery: the time is now (2022) (3)
- Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing (2022) (3)
- Helicobacter pylori—More Light, Less Heat (1998) (3)
- Cost-effectiveness of once in a lifetime screening unsedated endoscopy in 50 year-old white males with uncomplicated GERD (2001) (3)
- A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy (2000) (3)
- What do primary care physicians think about Barrett's esophagus, the relationship between GERD & H. pylori, and treatment of nocturnal heartburn? (2003) (3)
- Differences in physician compensation for cardiovascular services by age, sex, and race. (1997) (3)
- Access to innovative treatment of erectile dysfunction: clinical, economic, and quality-of-life considerations. (2000) (3)
- PHARMACY MANAGEMENT TRENDS: A GUIDE FOR NEW PHYSICIANS (2000) (3)
- Delivery of acute unscheduled healthcare: who should judge whether a visit is appropriate (or not)? (2018) (3)
- Value-based insurance design for diabetes mellitus: approaches to optimal pharmacoeconomic implementation. (2010) (3)
- Expanding coverage for essential care during COVID-19. (2020) (3)
- Impact of unsedated transnasal endoscopy (T-EGD) on the management of dyspepsia: A decision analysis (2001) (2)
- Short-term risk of stroke after dizziness presentation. Reply. (2014) (2)
- Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costs. (2017) (2)
- Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population (2022) (2)
- Impact of an Episode-Based Payment Initiative by Commercial Payers in Arkansas on Procedure Volume: an Observational Study (2019) (2)
- The challenges ahead for accountable care organizations (ACOs). (2011) (2)
- Cost-effectiveness of step-up vs. Step-down therapy for symptomatic gerd: An international perspective (2000) (2)
- Decision analytic modeling and NSAID gastropathy could we be more sensitive? (2000) (2)
- Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population (2018) (2)
- Understanding and improving value frameworks with real-world patient outcomes. (2018) (2)
- Confronting hysteria: a reply to Fairman and Curtiss. (2008) (2)
- Value-Based Insurance Design in the Medicare Prescription Drug Benefit: An Analysis of Policy Options (2009) (2)
- Cost Sharing for Emergency Surgical Conditions-The Moral, Clinical, and Financial Hazards. (2021) (2)
- Clinical and economic assessment of new surgical technologies. (1995) (2)
- Endoscopic outcomes analysis. (2001) (2)
- Is all "skin in the game" fair game? The problem with "non-preferred" generics. (2014) (2)
- Refining the Recipe for Alternative Payment Models for Surgical Care-Importance of Patient Mix and Venue Match. (2021) (2)
- Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studies. (2003) (2)
- The impact of over-the-counter histamine-2-antagonists: Great expectations unfulfilled (1998) (2)
- Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes (2021) (2)
- Enhance care continuity post COVID-19. (2021) (2)
- Prevalence and Magnitude of Potential Surprise Bills for Childbirth (2021) (2)
- Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending (2022) (2)
- Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States (2021) (1)
- Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection (2022) (1)
- Predicting effects of minimal invasive therapy. (1996) (1)
- Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition (2022) (1)
- Cost sharing and branded antidepressant initiation among patients treated with generics. (2018) (1)
- Thrombolytic therapy: just do it. (1995) (1)
- The impact of value-based insurance design on oncology drugs. (2016) (1)
- EPR22-119: Cost-Effectiveness of Multi-Cancer Early Detection (MCED) Test in Subgroups With Smoking History or Obesity (2022) (1)
- The role of physical therapy in occupational low back injuries. (2002) (1)
- Thrombolytic therapy (1995) (1)
- Impact of academic detailing and on-site serologic testing forH. pywrion management of suspected peptic ulcer disease by primary care providers (2000) (1)
- Comparative effectiveness research and formulary placement: the case of diabetes. (2013) (1)
- The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19. (2020) (1)
- The economics of resistant pathogens and antibiotic innovation. (2014) (1)
- Cost-Sharing and Productivity (2012) (1)
- State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations. (2022) (1)
- Measures of the Burden of Medical Expenses. (2018) (1)
- Tu1822 HIGHER IMPACT ON CLINICAL OUTCOMES FROM DELAYS IN COLORECTAL CANCER SCREENING WITH THE FECAL IMMUNOCHEMICAL TEST VS MULTITARGET STOOL DNA: CRC-AIM MICROSIMULATION MODEL RESULTS (2020) (1)
- HEALING AND PREVENTION OF NSAID-ASSOCIATED ULCER DISEASE: IS SEEING BELIEVING? (1998) (1)
- Alignment of Consumer and Provider Incentives: As Easy as Peanut Butter and Jelly (2014) (1)
- Precision Benefit Design: Using Clinical Benefit to Guide How Health Care Dollars Are Spent (2018) (1)
- Economic immunity in the ICU: continued support or pull the plug? (1999) (1)
- Randomized trial of H. pylori test-and-treat intervention for primary care patients with suspected peptic ulcer disease (2000) (1)
- CT colonography: Friend or foe of practicing endoscopists. (2009) (1)
- Peptic Ulcer Guideline Team (2005) (1)
- The Role of Gastroprotection in Patients on NSAID Therapy (2006) (1)
- Economic evaluation of alternative adjuvant chemotherapy modalities for colorectal carcinoma. (1996) (1)
- Cardiovascular risk reduction in the workforce: Optimizing cholesterol management to reduce the burden of cardiovascular disease (2010) (1)
- Why Not Africa? An Exploration of the Correlation Between International Sporting Events and Development (2013) (1)
- POSB44 Drivers of Value-Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test (2022) (1)
- Sa1658 MICROSIMULATION STUDY OF LIFE-YEARS GAINED FROM SCREENING VERSUS FOLLOW-UP COLONOSCOPY USING THE CRC-AIM MODEL (2020) (1)
- Precision medicines need precision patient assistance programs. (2019) (1)
- Expand predeductible coverage without increasing premiums or deductibles. (2020) (1)
- HELICOBACTER PYLORI ERADICATION: KILL THE BUG AND SAVE THE PILL? (1998) (1)
- Healthcare Utilization in Community-Acquired Pneumonia Episodes of Care: A Comparison Across the Continuum of Managed Care (2009) (1)
- Timing and Timeliness in Medical Care Evaluation (1996) (1)
- PCN7: FAMILY CAREGIVING COSTS FOR THE ELDERLY WITH CANCER: ESTIMATES FROM A REPRESENTATIVE SAMPLE OF THE UNITED STATES (2000) (1)
- Meeting the challenge of colorectal cancer screening. (2005) (1)
- The clinical and economic effects of silver alloy urinary catheters to prevent urinary tract infection (1999) (1)
- Self-reported use and benefit of over-the-counter histamine-2-receptor anatagonists in the community (2003) (1)
- The drug price iceberg: more than meets the eye. (2019) (1)
- The Economics of Viagra Revisited: The Price Is Right (2021) (1)
- The Changing Health Insurance Coverage Landscape in the United States. (2020) (1)
- Putting value into practice. (2012) (0)
- PMI15: COST ANALYSIS FOR END-OF-LIFE CARE (2001) (0)
- Cost and Effectiveness of Hepatitis B Immunization (1993) (0)
- Opportunity after crisis: enhancing value in the COVID-19 rebound. (2022) (0)
- Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic (2022) (0)
- Reply (2014) (0)
- Cancer Patients Need Better Information, and Payers Should Demand They Receive It (2014) (0)
- PAR2 THE IMPACT OF SPECIALTY CARE ON THE UTILIZATION OF NEW DRUGS: THE CASE OF COX-2 SELECTIVE INHIBITORS (2005) (0)
- The Need For Outcomes Research In Evaluating The Benefit Of Health Care Technology (1994) (0)
- Clinical and economic impact of population-based screening for hepatitis C: A decision analysis (2000) (0)
- A Word From the New Editors (2002) (0)
- H. pylori eradication for individuals on chronic NSAID therapy: Should we kill the bug if you need the drug? (2001) (0)
- Women'sHealthandtheAffordableCareAct:HighHopes VersusHarshRealities? (2014) (0)
- EE126 Cost-Effectiveness of Multi-Cancer Early Detection (MCED) Testing Using Mixture Cure Modeling (MCM) (2022) (0)
- EE5 Assessment of Value Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test in a Medicare Population (2022) (0)
- The Patient Referred for EGD: An Opportunity for CRC Screening (2005) (0)
- Factors associated with employee participation in a value-based insurance design initiative (2013) (0)
- Abstract W P293: Opportunities For Interventions In Stroke-Dizziness Presentations: A Prospective Single Center Surveillance Study (2015) (0)
- COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING STRATEGIES. AUTHOR'S REPLY (1996) (0)
- Estimating t he C ost o f I nformal C aregiving f or E lderly Patients W ith C ancer (2001) (0)
- Benefit Design to Promote Effective, Efficient, and Affordable Care: A Vital Direction for Health and Health Care (2016) (0)
- Book reviews (2007) (0)
- Tailoring complex care to patients' needs: myths, realities, and best next steps. (2021) (0)
- Su053 COST-EFFECTIVENESS OF STOOL-BASED COLORECTAL CANCER SCREENING USING REPORTED REAL-WORLD ADHERENCE RATES IN A MEDICARE POPULATION (2021) (0)
- Insights on site-of-care cancer research: both quality and cost information are necessary to guide policy. (2018) (0)
- Highlights of this Issue (2004) (0)
- The Debate Over Drug Costs: Instead of “How Much” We Spend, Let’s Focus on What We Get in Terms of Health (2015) (0)
- Taking aim at short-term, short-sighted cost minimization. (2014) (0)
- TRANSLATING KNOWLEDGE INTO POLICY: THE CASE OF VALUE BASED INSURANCE DESIGN (2014) (0)
- Eliminating Financial Barriers to Breast Cancer Screening-When Free Is Not Really Free. (2023) (0)
- Developing dialogue in health care. (2011) (0)
- Economic Evaluation of Vaccination ProgrammesStatement Focusing on Viral Hepatitis (2002) (0)
- Proteinuria and oral gold treatment. (1985) (0)
- Beta-blocker use in heart failure: Should we pick up the pace in patients with low heart rates? (2003) (0)
- After 25 years, AJMC® looks to the future: a Q&A with Michael E. Chernew, PhD, and A. Mark Fendrick, MD. (2020) (0)
- Slowing in Healthcare Costs: Hold the Celebration (2014) (0)
- PCV87 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION (2010) (0)
- Development of a brief reflux disease question-naire (2000) (0)
- HSR23-100: The Potential Clinical Impact of a Multi-Cancer Early Detection Test for Individuals With Missing Cancer Stage Information (2023) (0)
- Informed choices in anti-inflammatory drug therapy: why patient risk matters. (2004) (0)
- Reallocating Cervical Cancer Preventive Service Spending from Low to High-Value Clinical Scenarios. (2023) (0)
- Taking stock at 2 years--continuing the journey. (2004) (0)
- Characteristics and health service utilization of women enrolled in health plans still requiring cost-sharing for intrauterine device placement in 2014 (2016) (0)
- Letter to the editor (multiple letters) (2004) (0)
- Cost-Effectiveness of mt-sDNA versus Mailed FIT Outreach for Medicare Advantage Enrollees using the CRC-AIM Microsimulation Model (2022) (0)
- Influence of induced abortion training on attitudes and treatment patterns for early pregnancy failure (2009) (0)
- Stopping the flood: reducing harmful cascades of care. (2021) (0)
- “Clinically nuanced” Medicaid cost-sharing (2018) (0)
- Accountable Care Organizations: Looking for Answers to an Overspending, Underachieving System (2013) (0)
- Waiving cost sharing for screening colonoscopy; free, but not clear. (2012) (0)
- Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan. (2022) (0)
- The Use of the Dix-Hallpike Test and the Canalith Repositioning Maneuver in Emergency Department Dizziness Presentations: A Population-Based Study (P02.250) (2012) (0)
- Informal Caregiving for Diabetes and Diabetic Complications Among Elderly Americans (2001) (0)
- Baffled by NAFLD: the horse might be out of the barn but should not take us for a ride. (2021) (0)
- PAO22 REFILL ADHERENCE IN OSTEOPOROTIC WOMEN WITH PRIMARY AND SECONDARY FRACTURE PREVENTION (2002) (0)
- Toward a national hepatitis B vaccination program. (1994) (0)
- Need for outcomes research in evaluating the benefit of new health care technology (1994) (0)
- Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy (2023) (0)
- Equity enhancing policies that increase access and affordability of cervical cancer screening in the United States: A Preventive Medicine Golden Jubilee Commentary. (2022) (0)
- Impact Of Decreasing Copayments OnMedication AdherenceWithin A Disease Management Environment Value-based cost sharing can increase patients ’ adherence to important medications (2007) (0)
- The Hidden Value of Upper Endoscopy: A “Teachable Moment” for Colorectal Cancer Screening (2005) (0)
- Developing dialogue in healthcare. (2011) (0)
- Coverage for the Entire Cervical Cancer Screening Process Without Cost-Sharing: Lessons From Colorectal Cancer Screening. (2022) (0)
- S266 Lifetime Impact of the Change in Modality as a Result of Eliminating Cost-Sharing for Follow-Up Colonoscopy After a Positive Stool Test for Colorectal Cancer Screening (2022) (0)
- Open doors to primary care should add a "screen" to reduce low-value care. (2019) (0)
- Correspondence regarding "A benefit-based copay for prescription drugs" [1] (multiple letters) (2002) (0)
- Physician utilizaton by consumers of OTC proton pump inhibitors (2003) (0)
- P19 Utilization of Low-Value and High-Value Care and Its Association with Cognitive Impairment (2022) (0)
- The Editors Respond Regarding the Shortcomings in Reported Research on Value-Based Insurance Design (2008) (0)
- The use and effect of OTC omeprazole for frequent heartburn (2002) (0)
- How Might Patients and Physicians Use Transparent Health Care Prices to Guide Decisions and Improve Health Care Affordability? (2022) (0)
- PAO21 MISSED OPPORTUNITIES IN PHARMACEUTICAL TREATMENT OF OSTEOPOROSIS IN POST-FRACTURE WOMEN (2002) (0)
- Letter--Assessing the Effectiveness of V-BID Implementations. (2019) (0)
- PCV31 US BUDGET IMPACT OF INCREASING ASPIRIN USAGE FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE (2009) (0)
- Setting Priorities for Medicaid: The Views of Minority and Underserved Communities (2017) (0)
- In response [7] (2005) (0)
- EM4: CAN UNIT COSTS BE COMPARED ACROSS WESTERN EUROPEAN COUNTRIES? (2011) (0)
- Changes in use of low-value services during the COVID-19 pandemic. (2022) (0)
- PRACTICE MANAGEMENT: OPPORTUNITIES AND CHALLENGES Value-Based Insurance Design: Implications for Gastroenterology (2010) (0)
- Changing the Health Care Cost Discussion from "How Much" to "How Well" (2015) (0)
- Prevention of colorectal cancer with cox-2 inhibitors is unlikely to be cost-effective (2003) (0)
- A reappraisal of hepatitis B virus vaccination strategies using cost‐effectiveness analysis (1993) (0)
- Evidence in Oncology Value-Based Insurance Design : Aligning Incentives , Benefits , and (2011) (0)
- PRP10: VARIATIONS IN COVERAGE FOR EFFECTIVE SERVICES FOR ASTHMA: IMPACT OF NATIONAL GUIDELINES (2001) (0)
- ES1 COST-UTILITY ANALYSES OF NEW MEDICAL TECHNOLOGIES: OFTEN COST-EFFECTIVE, SOMETIMES COST-INEFFECTIVE, DOMINANT, OR DOMINATED, BUT ALMOST NEVER ‘DECREMENTALLY’ COST-EFFECTIVE (2006) (0)
- Su1773 MORE FECAL IMMUNOCHEMICAL TESTS ARE NEEDED TO MATCH THE CLINICAL BENEFIT OF EQUIVALENT NUMBERS OF MULTITARGET STOOL DNA TESTS: CRC-AIM MICROSIMULATION MODEL RESULTS (2020) (0)
- Ease of ordering high- and low-value services in various electronic health records. (2019) (0)
- Putting money into effective treatments. (2002) (0)
- Evaluation of a Best Practice Advisory on Ordering Prothrombin Time, International Normalized Ratio, and Partial Thromboplastin Time Tests. (2022) (0)
- Determining the Benefits of Gender-Affirming Surgery-A Call for Action. (2021) (0)
- A Physician Survey of Clinical Practice (2016) (0)
- Variation in Women’s out of Pocket Costs for Preventive Services: Implications for Evaluations of the Affordable Care Act (2017) (0)
- High Deductibles are Associated with Severe Disease, Catastrophic Out-of-pocket Payments for Emergency Surgical Conditions. (2023) (0)
- Shifting away from emergency department and office-based urgent care: no place like home? (2022) (0)
- The provider culture vis-à-vis new technologies may have greater impact on cost growth than health plans' cost containment strategies. (2004) (0)
- Early impact of the Affordable Care Act: changes in cost sharing and women's use of preventive services (2016) (0)
- PCN280 IMPACT OF ALIGNED SCREENING INTERVAL ON SCREENING OUTCOMES USING THE CRC-AIM MICROSIMULATION MODEL (2020) (0)
- Low-Cost , High-Volume Health Services Contribute The Most To Unnecessary Health Spending An analysis of data for 2014 about forty-four low-value health services in the Virginia All Payer Claims Database (2017) (0)
- Ten Years of Choosing Wisely to Reduce Low-Value Care. (2022) (0)
- HP1 SUB-OPTIMAL STATIN COMPLIANCE IN PRIMARY AND SECONDARY PREVENTION POPULATIONS: SHOULD WE TARGET PATIENTS WITH THE MOST TO GAIN? (2002) (0)
- "Benefit Design in the Post-ACA Environment" (2014) (0)
- PCN289 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL (2020) (0)
- CN4: THE IMPACT OF THE DIAGNOSIS OF CANCER ON OUT-OF-POCKET HEALTH-CARE EXPENDITURES MADE BY THE US ELDERLY (2001) (0)
- Value-Based Insurance Design in Cardiology (2012) (0)
- Refining intensive care management programs: can providing the neediest patients the right care in the right setting improve health and reduce expenditures? (2022) (0)
- Celebrating our 20th anniversary. (2015) (0)
- Treatment patterns for early pregnancy failure among Michigan Medicaid participants (2006) (0)
- The Utilization and Costs of USPSTF Grade D Services in Medicare, 2007‐2016 (2020) (0)
- A new chapter in health reform. (2016) (0)
- MD1: COST-EFFECTIVENESS OF AIRLINE DEFIBRILLATORS: IS PEACE OF MIND MORE IMPORTANT THAN SAVING LIVES? (2001) (0)
- Welcome to JVBHM 2 Aspirin Therapy Targets CVD Risk 3 Drive Participation , Increase Effectiveness 3 Q & A : (2008) (0)
- Fr553 PATIENT PERCEPTIONS ON TRANSITION FROM CLINIC-BASED INFUSIONS TO HOME-BASED INFUSIONS FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: A QUALITATIVE QUALITY IMPROVEMENT STUDY (2021) (0)
- Women’s ACA knowledge and attitudes: implications for reproductive health care access, utilization and equity (2014) (0)
- C12. Management and patients with past documented duodenal ulcer but unknown Helicobacter pylori status (1996) (0)
- Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension (2022) (0)
- Outcomes research in evaluating the benefit of health care technology (1995) (0)
- The program on outcomes research in technology. (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With A. Mark Fendrick?
A. Mark Fendrick is affiliated with the following schools: